The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dacomitinib API Market Research Report 2025
Synopsis
Single agent for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion mutations or exon 21 L858R substitution mutations.
The global Dacomitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dacomitinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dacomitinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dacomitinib API include Chengdu Beite Pharmaceutical and Pfizer etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dacomitinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dacomitinib API.
Report Scope
The Dacomitinib API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dacomitinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dacomitinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu Beite Pharmaceutical
Pfizer
Segment by Type
≥99%
≥98%
Segment by Application
Pharmaceutical
Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dacomitinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dacomitinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dacomitinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Single agent for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion mutations or exon 21 L858R substitution mutations.
The global Dacomitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dacomitinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dacomitinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dacomitinib API include Chengdu Beite Pharmaceutical and Pfizer etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dacomitinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dacomitinib API.
Report Scope
The Dacomitinib API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dacomitinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dacomitinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu Beite Pharmaceutical
Pfizer
Segment by Type
≥99%
≥98%
Segment by Application
Pharmaceutical
Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dacomitinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dacomitinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dacomitinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Dacomitinib API Market Overview
1.1 Product Definition
1.2 Dacomitinib API Segment by Type
1.2.1 Global Dacomitinib API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 ≥99%
1.2.3 ≥98%
1.3 Dacomitinib API Segment by Application
1.3.1 Global Dacomitinib API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Research
1.4 Global Market Growth Prospects
1.4.1 Global Dacomitinib API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dacomitinib API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dacomitinib API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dacomitinib API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dacomitinib API Production Market Share by Manufacturers (2019-2024)
2.2 Global Dacomitinib API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dacomitinib API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Dacomitinib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dacomitinib API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dacomitinib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dacomitinib API, Product Offered and Application
2.8 Global Key Manufacturers of Dacomitinib API, Date of Enter into This Industry
2.9 Dacomitinib API Market Competitive Situation and Trends
2.9.1 Dacomitinib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dacomitinib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dacomitinib API Production by Region
3.1 Global Dacomitinib API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dacomitinib API Production Value by Region (2019-2030)
3.2.1 Global Dacomitinib API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dacomitinib API by Region (2025-2030)
3.3 Global Dacomitinib API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dacomitinib API Production by Region (2019-2030)
3.4.1 Global Dacomitinib API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dacomitinib API by Region (2025-2030)
3.5 Global Dacomitinib API Market Price Analysis by Region (2019-2024)
3.6 Global Dacomitinib API Production and Value, Year-over-Year Growth
3.6.1 North America Dacomitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Dacomitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dacomitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Dacomitinib API Production Value Estimates and Forecasts (2019-2030)
4 Dacomitinib API Consumption by Region
4.1 Global Dacomitinib API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dacomitinib API Consumption by Region (2019-2030)
4.2.1 Global Dacomitinib API Consumption by Region (2019-2024)
4.2.2 Global Dacomitinib API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dacomitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dacomitinib API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dacomitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dacomitinib API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Dacomitinib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dacomitinib API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dacomitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dacomitinib API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dacomitinib API Production by Type (2019-2030)
5.1.1 Global Dacomitinib API Production by Type (2019-2024)
5.1.2 Global Dacomitinib API Production by Type (2025-2030)
5.1.3 Global Dacomitinib API Production Market Share by Type (2019-2030)
5.2 Global Dacomitinib API Production Value by Type (2019-2030)
5.2.1 Global Dacomitinib API Production Value by Type (2019-2024)
5.2.2 Global Dacomitinib API Production Value by Type (2025-2030)
5.2.3 Global Dacomitinib API Production Value Market Share by Type (2019-2030)
5.3 Global Dacomitinib API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dacomitinib API Production by Application (2019-2030)
6.1.1 Global Dacomitinib API Production by Application (2019-2024)
6.1.2 Global Dacomitinib API Production by Application (2025-2030)
6.1.3 Global Dacomitinib API Production Market Share by Application (2019-2030)
6.2 Global Dacomitinib API Production Value by Application (2019-2030)
6.2.1 Global Dacomitinib API Production Value by Application (2019-2024)
6.2.2 Global Dacomitinib API Production Value by Application (2025-2030)
6.2.3 Global Dacomitinib API Production Value Market Share by Application (2019-2030)
6.3 Global Dacomitinib API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Chengdu Beite Pharmaceutical
7.1.1 Chengdu Beite Pharmaceutical Dacomitinib API Corporation Information
7.1.2 Chengdu Beite Pharmaceutical Dacomitinib API Product Portfolio
7.1.3 Chengdu Beite Pharmaceutical Dacomitinib API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Chengdu Beite Pharmaceutical Main Business and Markets Served
7.1.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
7.2 Pfizer
7.2.1 Pfizer Dacomitinib API Corporation Information
7.2.2 Pfizer Dacomitinib API Product Portfolio
7.2.3 Pfizer Dacomitinib API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Pfizer Main Business and Markets Served
7.2.5 Pfizer Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dacomitinib API Industry Chain Analysis
8.2 Dacomitinib API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dacomitinib API Production Mode & Process
8.4 Dacomitinib API Sales and Marketing
8.4.1 Dacomitinib API Sales Channels
8.4.2 Dacomitinib API Distributors
8.5 Dacomitinib API Customers
9 Dacomitinib API Market Dynamics
9.1 Dacomitinib API Industry Trends
9.2 Dacomitinib API Market Drivers
9.3 Dacomitinib API Market Challenges
9.4 Dacomitinib API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
